April 12, 2022

CYTO

Altamira Therapeutics Ltd. (CYTO) Under Corrections Premarket After Huge Uptick on Covid-19 Nasal Spray Data

Yesterday, Altamira Therapeutics Ltd. (CYTO) saw a huge uptick after it announced the publication of its Covid-19 nasal spray data in IJMS. The stock rallied by over 55% in the regular trading session to mark the close of the day at $1.66 apiece. In today’s premarket session on April 12, CYTO has succumbed to corrections …

Altamira Therapeutics Ltd. (CYTO) Under Corrections Premarket After Huge Uptick on Covid-19 Nasal Spray Data Read More »

BDSX

Biodesix Inc. (BDSX) Skyrockets After Hours on Stock Purchase by Chairman and Certain Directors

The lung disease-focused diagnostic company, Biodesix Inc. (BDSX) stock while suffering a decline in regular trading on Monday, skyrocketed in the after hours. The downfall was a result of the company’s announcement of a private placement and an amendment to its term loan. But thankfully, the SEC filings regarding stock purchases by certain board members …

Biodesix Inc. (BDSX) Skyrockets After Hours on Stock Purchase by Chairman and Certain Directors Read More »

AGLE

Aeglea BioTherapeutics Inc. (AGLE) Surges After Hours on Additional Data for Rare Disorder Presentation

On April 11, Aeglea BioTherapeutics Inc. (AGLE) stock rallied by nearly 28% in the after-hours trading at a heavy shares traffic of 1.28 million. Thus, the stock surged up to $3.11 a share in the session after it closed the prior session at $2.43 with a decline of 6.54%. The reason for the after-hours rally …

Aeglea BioTherapeutics Inc. (AGLE) Surges After Hours on Additional Data for Rare Disorder Presentation Read More »

ATHX Stock

Athersys Inc. (ATHX) Rebounds Only to Fall Once Again. What’s Going on?

On April 11, Athersys Inc. (ATHX) stock rebounded after a long fall to increase by 63.00% during the regular trading session. But the uptrend could not last any longer as the stock fell under corrections in the after-hours to shed 11.51%. Thus, after reaching $0.8600 in regular trading, ATHX plunged down to $0.7610 in the …

Athersys Inc. (ATHX) Rebounds Only to Fall Once Again. What’s Going on? Read More »

PTE stock

PolarityTE Inc. (PTE) stock Bounces Back After Hours Following its Descent to New Low

The regenerative tissue and biomaterials developer, PolarityTE Inc. (PTE) finally made a comeback in the after-hours on April 11, 2022. The stock had been in a long downtrend which culminated in its new 52-week in the prior session. Thus, after closing the regular session near the new low, PTE rebounded and rose by 42.67% in …

PolarityTE Inc. (PTE) stock Bounces Back After Hours Following its Descent to New Low Read More »

HOTH stock

Hoth Therapeutics Inc. (HOTH) Rally on HT-KIT’s Cancer Response Cut Short by Propose Offering After Hours

Hoth Therapeutics Inc. (HOTH) had meme-like trading on April 11, 2022. The biopharmaceutical company released development updates for its novel cancer therapeutic, HT-KIT which prevented cancer cell growth. The positive data caused an upswing by a huge 70.48% in HOTH stock during regular trading. Consequently, the stock reached a value of $1.05 at the end …

Hoth Therapeutics Inc. (HOTH) Rally on HT-KIT’s Cancer Response Cut Short by Propose Offering After Hours Read More »

VERU stock

Veru Inc. (VERU) Remains Bullish on Game Changing Covid-19 Treatment Candidate

On April 11, Veru Inc. (VERU) announced game-changing clinical study results for its Covid-19 oral drug candidate, sabizabulin. Consequently, investors rallied towards the stock to make it soar by a mammoth 182.30% during the regular session. Continuing its bullishness into the after-hours, VERU reached $13.95 after closing the prior session at $12.28. Thus, the stock …

Veru Inc. (VERU) Remains Bullish on Game Changing Covid-19 Treatment Candidate Read More »